Ranolazine for Congenital Long QT Syndrome Type III (LQT3): Experimental and Long-Term Clinical Data

BACKGROUND: The basic defect in long QT syndrome type-III (LQT3) is an excessive inflow of sodium current during phase-3 of the action potential caused by mutations in the SCN5A gene. Most sodium channel blockers reduce the early (peak) and late components of the sodium current (I(Na) and I(NaL)) bu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Arrhythm Electrophysiol
Main Authors: Chorin, Ehud, Hu, Dan, Antzelevitch, Charles, Hochstadt, Aviram, Belardinelli, Luiz, Zeltser, David, Barajas-Martinez, Hector, Rozovski, Uri, Rosso, Raphael, Adler, Arnon, Benhorin, Jesaia, Viskin, Sami
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119553/
https://ncbi.nlm.nih.gov/pubmed/27733495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCEP.116.004370
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados